Doublewin Biological Technology Co., Ltd.(expird)
Free supplier Enterprise Certification
- Free
supplier - 4th
years
Free supplier Enterprise Certification
Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough;
3. Package: Professional packing with professional materials
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived.
Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 4-7 working days.
5. Service: Best Service with after-sales service and consultation.
Name:Clomifene citrate (clomid)
English synonyms:Serophene;Pergotime;Clomphid;Clomid;Clomifene citrate;Clomiphene citrate;
Clomiphene citrate salt;2-[4-(2-chloro-1,2-diphenylethenyl)-phenoxy]-n,n-diethylethanamine citrate salt
NO.: 50-41-9
EINECS: 200-035-3
Molecular Formula:C32H36ClNO8
Molecular Weight:598.08
Quality Standard: USP
Assay: 98%
Appearance: White or white crystalline powder. Melting point 116.5-118, slightly soluble in ethanol, chloroform, water
Usage: The product is anti-estrogen (fertility inducing object), in dysfunctional uterine bleeding,
polycystic ovary, menstrual disorders, and drug-induced amenorrhea and other gynecological diseases.
Packing:1kg/foil bag or as required.
Detailed information:
Clomid is available in 50 mg tablets. Treatment of the selected patient should begin with a low dose, 50 mg daily (1 tablet) for 5 days; dose changes are made by the treating physician. The first dose should occur on the 5th day of the female's ovulatory cycle and then subsequent doses at about the same time of day for a total of 5 days. Patients should be familiar with their ovulatory cycle so that properly timed coitus and ovulation stimulated by the drug occur.
Application:
Stop taking clomiphene and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).
The ovarian hyperstimulation syndrome (OHSS) has been reported to occur in patients receiving clomiphene. Symptoms of OHSS include swelling of the hands or legs, abdominal pain and swelling, shortness of breath, weight gain, and nausea or vomiting. OHSS can be fatal. Notify your doctor immediately or seek emergency medical attention if you develop any of these side effects.